AusCann Group Holdings Ltd
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AC8.AX research report →
Price Chart
About the company
Based in West Perth, Australia, AusCann Group Holdings Ltd currently lacks substantial business operations. Historically, the company specialized in the research, development, and commercialization of various therapeutic products derived from cannabinoids.
- CEO
- Christopher Mews B. Bus,
- IPO
- 1988
- Employees
- 27
- HQ
- West Perth, WA, AU
Get TickerSpark's AI analysis on AC8.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $17.62M
- P/E
- -1.63
- PEG
- -0.02
- P/S
- 15.92
- P/B
- 1.03
- EV/EBITDA
- -3.96
- Div Yield
- 0.00%
- Gross Margin
- 95.84%
- Op Margin
- -124.75%
- Net Margin
- -977.06%
- ROE
- -61.32%
- ROIC
- -12.12%
Latest fiscal year · YoY change
- Revenue
- $1.11M-26.9%
- Gross Profit
- $1.06M+163.5%
- Op Income
- $-1,381,000
- Net Income
- $-10,816,000+59.0%
- EPS
- $-0.02+58.9%
- OCF Growth
- -17.6%
- FCF Growth
- -25.4%
- 52W High
- $0.04
- 52W Low
- $0.04
- 50D MA
- $0.04
- 200D MA
- $0.04
- Beta
- 0.73
- RSI (14)
- 41
- Avg Volume
- 0
No earnings-call transcripts are available for AC8.AX yet.
- Free Float
- 0.0%
- Shares Outstanding
- 440.55M
- Float Shares
- 0
of shares held by institutions
1 13F filers
Our AC8.AX coverage
Recent articles, reports, and earnings notes.
No research on AC8.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AC8.AX report →